Trial
NCT00787267
Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
Bristol-Myers Squibb
Condition
Non Small Cell Lung Cancer
Intervention
Dasatinib
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-30